SARS-CoV-2 N protein nucleocapsid (COVID-19)

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

NUCLEOCAPSID ANTIGEN IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND METHODS OF USE
申请人: VAKSTON INC优先权: 2023
CN
EP
WO
3 件公开
Antibody specifically binding to novel coronavirus
申请人: THE FIFTH AFFILIATED HOSPITAL SUN YAT SEN UNIV优先权: 2020
CN
COMPOSITION FOR USE IN THE TREATMENT OF COVID-19
申请人: UNIV KING ABDULLAH SCI & TECH优先权: 2021
WO
293T-nCoV N cell model as well as construction method and application thereof
申请人: UNIV EAST CHINA NORMAL优先权: 2021
CN
Recombinant mycobacterium smegmatis, vaccine and application thereof
申请人: GUANGZHOU INST BIOMED & HEALTH优先权: 2021
CN
PIV5-based coronavirus vaccines and methods of use thereof
申请人: UNIV GEORGIA优先权: 2022
CN
NEW DNA SARS-COV-2 VACCINE
申请人: CONSEJO SUPERIOR INVESTIGACION优先权: 2022
EP